| Trial registration number
|
IRCT20210426051090N1 |
Full text link
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/56387
|
First author
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mehraban Sadeghy
|
Contact
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
st-moghaddam.sh@skums.ac.ir
|
Registration date
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-06-12
|
Recruitment status
Last imported at : Aug. 25, 2021, 6:48 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Patients with confirmed molecular test of blood oxygen saturation level SpO2 less than 90% in room air
Patients with pulmonary involvement in radiological studies
Do not take statins
The patient is not in a state of shock and sepsis
|
Exclusion criteria
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Having advanced heart disease (CHF)
Liver disease (based on primary LFT)
Incidence of statin side effects
Long-term use of corticosteroids
to die
Pulmonary underlying disease
|
Number of arms
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Shahre-kord University of Medical Sciences
|
Inclusion age min
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
80
|
primary outcome
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
O2 Saturation
FBS
IL-6
Alt، Ast ،Alkp ، Bill total ، Bill direct
BUN, Na, K, Cr
PT, PTT, INR
TG, Total Cholesterol, LDL, HDL
CBC(diff)
LDH
ESR
CRP
Ferritin
|
Notes
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : June 13, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 137, "treatment_name": "Atorvastatin", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|